Medicine

Projects

Projects per year 1975 1989 2002 2005 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2025

• 25 Not started
• 128 Active
• 802 Finished

Projects per year

Search results

• Active

  Characteristics and protective efficacy of human antibodies against M. tuberculosis

  Achkar, J. M.

  National Institute of Allergy and Infectious Diseases

  7/1/19 → 6/30/22

  Project: Research project

  • Tuberculosis 100%
  • Mycobacterium tuberculosis 76%
  • Antibodies 55%
  • Polysaccharides 49%
  • Tuberculosis Vaccines 37%

• Functional role of IP3 receptors in the regulation of cardiac myofibroblasts

  Santulli, G.

  National Heart, Lung, and Blood Institute

  7/1/19 → 6/30/22

  Project: Research project

  • Inositol 1,4,5-Trisphosphate Receptors 100%
  • Myofibroblasts 83%
  • Fibroblasts 60%
  • Fibrosis 49%
  • Myocardial Infarction 31%

• Somatotropic Signaling and Resilience to Aging and Alzheimer's Disease

  Milman, S.

  National Institute on Aging

  4/15/19 → 1/31/23

  Project: Research project

  • Alzheimer Disease 100%
  • Aged, 80 and over 45%
  • Dementia 39%
  • Pandemics 37%
  • SARS Virus 37%

• Vulnerability of SCLC based on bi-allelic genetic inactivation of RB1 and TP53

  Zhao, H. & Schwartz, E. L.

  4/12/19 → 3/31/22

  Project: Research project

  • Small Cell Lung Carcinoma 100%
  • Drug Therapy 17%
  • Heterografts 16%
  • Ubiquitination 13%
  • Neoplasms 11%

• IgM in the regulation of TB immunity

  Chan, J. & Chan, J.

  National Institute of Allergy and Infectious Diseases

  2/15/19 → 1/31/23

  Project: Research project

  • Immunoglobulin M 100%
  • Mycobacterium tuberculosis 96%
  • Immunity 80%
  • Germinal Center 61%
  • Humoral Immunity 20%

• Hemolysis and Platelet Activation during Continuous Flow Mechanical Circulatory Support

  Saeed, O. & Saeed, O.

  National Heart, Lung, and Blood Institute

  1/15/19 → 12/31/22

  Project: Research project

  • Hemolysis 100%
  • Platelet Activation 98%
  • Stroke 34%
  • Thrombosis 34%
  • Platelet Aggregation 33%

• Mechanisms of cardiovascular disease

  Kitsis, R. N. & Sibinga, N. E. S.

  National Heart, Lung, and Blood Institute

  1/1/19 → 12/31/22

  Project: Research project

  • Cardiovascular Diseases 100%
  • Molecular Biology 26%
  • Research Personnel 22%
  • Cardiologists 18%
  • Vascular Diseases 16%

• Integrative, age-related changes in genome and epigenome in human lung in relation to smoking

  Spivack, S. D. & Vijg, J.

  National Heart, Lung, and Blood Institute

  1/1/19 → 12/31/22

  Project: Research project

  • Epigenome 100%
  • Smoking 62%
  • Genome 54%
  • Lung Diseases 51%
  • Lung 49%

• Developmental PBDE exposure, gut microbiome, and diabetes

  CUI, Y., Gu, H., Mani, S. & Gu, H.

  National Institute of Environmental Health Sciences

  1/1/19 → 12/31/22

  Project: Research project

  • Halogenated Diphenyl Ethers 100%
  • Gastrointestinal Microbiome 56%
  • Dysbiosis 36%
  • Indoles 26%
  • Tryptophan 26%

• The Center of Excellence in Promoting LHS Operations and Research at Einstein/Montefiore (EXPLORE)

  Cunningham, C. O., Marantz, P. R. & Rinke, M. L.

  9/30/18 → 9/29/23

  Project: Research project

  • infrastructure 100%
  • health 97%
  • health care 51%
  • resources 46%
  • leader 45%

• Optimizing smoking cessation interventions for PLWH in Nairobi, Kenya

  Himelhoch, S. & Shuter, J.

  National Cancer Institute

  9/5/18 → 8/31/22

  Project: Research project

  • Kenya 100%
  • Smoking Cessation 89%
  • Acquired Immunodeficiency Syndrome 85%
  • Methadone 71%
  • HIV 70%

• Identification and targeting of pathways separating healthy stem cell aging from malignant transformation

  Will, B.

  National Cancer Institute

  9/1/18 → 8/31/22

  Project: Research project

  • Chaperone-Mediated Autophagy 100%
  • Cellular Senescence 55%
  • Stem Cells 42%
  • Hematopoietic Stem Cells 24%
  • Genetic Models 11%

• Identifying and Reducing Disparities in Outcomes Among Economically Vulnerable and Minority Young Adults with Type 1 Diabetes

  Agarwal, S.

  National Institute of Diabetes and Digestive and Kidney Diseases

  9/1/18 → 8/31/22

  Project: Research project

  • Type 1 Diabetes Mellitus 100%
  • Young Adult 90%

• Therapeutic targeting of MDS stem cells

  Steidl, U. G. & Verma, A. K.

  8/20/18 → 6/30/22

  Project: Research project

  • Interleukin-8 100%
  • Stem Cells 42%
  • Heterografts 17%
  • Disease Progression 15%
  • Interleukin-8 Receptors 14%

• Therapeutic targeting of MDS stem cells

  Steidl, U. G., Verma, A. K., Steidl, U. G. & Verma, A. K.

  National Heart, Lung, and Blood Institute

  8/20/18 → 6/30/22

  Project: Research project

  • Interleukin-8 100%
  • Stem Cells 71%
  • Heterografts 17%
  • Disease Progression 15%
  • Therapeutics 15%

• Assessing genome sequence integrity in normal human cells

  Spivack, S. D., Vijg, J. & Vijg, J.

  8/15/18 → 5/31/22

  Project: Research project

  • Mutation 100%
  • Genome 74%
  • Smoke 52%
  • Tobacco 52%
  • DNA 45%

• Assessing genome sequence integrity in normal human cells

  Spivack, S. D. & Vijg, J.

  National Institute of Environmental Health Sciences

  8/15/18 → 5/31/22

  Project: Research project

  • Genome 100%
  • Mutation 82%
  • DNA 39%
  • Smoke 39%
  • Tobacco 39%

• Microbial Metabolite Mimics, PXR and Colitis-Induced Colorectal Cancer

  Mani, S.

  National Cancer Institute

  8/14/18 → 7/31/22

  Project: Research project

  • Pregnane 100%
  • Metabolite 41%
  • Indole 23%
  • Non Toxic 8%

• Microbial Metabolite Mimics, PXR and Colitis-Induced Colorectal Cancer

  Mani, S.

  8/14/18 → 7/31/22

  Project: Research project

  • Pregnane 100%
  • Indole 22%
  • Metabolite 8%
  • Non Toxic 8%

• Calcification Propensity, using Dynamic Light Scattering, to Study Vascular Calcification in Patients with Advanced Chronic Kidney Disease

  Chen, W.

  8/1/18 → 5/31/22

  Project: Research project

  • Vascular Calcification 100%
  • Chronic Renal Insufficiency 27%
  • Dynamic Light Scattering 15%
  • Osteocalcin 12%
  • Biomarkers 11%

• Calcification Propensity, using Dynamic Light Scattering, to Study Vascular Calcification in Patients with Advanced Chronic Kidney Disease

  Chen, W.

  National Institute of Diabetes and Digestive and Kidney Diseases

  8/1/18 → 3/31/23

  Project: Research project

  • Vascular Calcification 100%
  • Dynamic Light Scattering 90%
  • Chronic Renal Insufficiency 64%
  • Osteocalcin 13%
  • Biomarkers 12%

• Apolipoprotein A5 and Gallstone Formation

  Wang, D. Q. H.

  7/20/18 → 4/30/22

  Project: Research project

  • apolipoproteins 100%
  • bile 58%
  • cholelithiasis 55%
  • cholesterol 30%
  • liver 26%

• A Major Nutritional Effect on Intestinal Stem Cells and Tumors

  Augenlicht, L. H.

  National Cancer Institute

  7/17/18 → 5/31/22

  Project: Research project

  • stem cells 100%
  • neoplasms 71%
  • carcinogenesis 44%
  • homeostasis 21%
  • cells 20%

• Genetic and Dietary Interactions in MMR Deficient Colon Tumorigenesis

  Edelmann, W., Augenlicht, L. H. & Edelmann, W.

  7/5/18 → 5/31/22

  Project: Research project

  • Hereditary Nonpolyposis Colorectal Neoplasms 100%
  • villin 59%
  • Colon 45%
  • Carcinogenesis 36%
  • Stem Cells 34%

• Nutritionally Driven Sporadic Intestinal Tumors: Impact on Stem Cells

  Augenlicht, L. H.

  National Cancer Institute

  7/5/18 → 5/31/22

  Project: Research project

  • stem cells 100%
  • neoplasms 71%
  • colorectal neoplasms 68%
  • homeostasis 60%
  • carcinogenesis 59%

• Genetic and Dietary Interactions in MMR Deficient Colon Tumorigenesis

  Augenlicht, L. H. & Edelmann, W.

  National Cancer Institute

  7/5/18 → 5/31/22

  Project: Research project

  • Colon 100%
  • Carcinogenesis 94%
  • Hereditary Nonpolyposis Colorectal Neoplasms 81%
  • villin 54%
  • Stem Cells 28%

• Thiamine as a Renal Protective Agent in Septic Shock

  Moskowitz, A. L.

  6/1/18 → 5/31/22

  Project: Research project

  • Thiamine 100%
  • Septic Shock 51%
  • Sepsis 30%
  • Thiamine Deficiency 27%
  • Kidney 23%

• Thiamine as a Renal Protective Agent in Septic Shock

  Moskowitz, A. L.

  National Institute of General Medical Sciences

  6/1/18 → 5/31/22

  Project: Research project

  • Renal Agents 100%
  • Thiamine 89%
  • Protective Agents 81%
  • Septic Shock 70%
  • Sepsis 29%

• Immunoregulation by indoleamine 2,3-dioxygenases in tuberculosis

  Porcelli, S. A., Chan, J. & Porcelli, S. A.

  5/1/18 → 4/30/22

  Project: Research project

  • Indoleamine-Pyrrole 2,3,-Dioxygenase 100%
  • Protein Isoforms 27%
  • Tuberculosis 24%
  • Immunosuppressive Agents 20%
  • Kynurenine 19%

• Clinical and Translational Science Award

  Keller, M. J., Shamoon, H. & Kim, M.

  National Center for Advancing Translational Sciences

  3/22/18 → 2/28/23

  Project: Research project

  • Translational Medical Research 100%
  • National Center for Advancing Translational Sciences (U.S.) 41%
  • Implementation Science 40%
  • Community Health Services 32%
  • Population Health 27%

• Cognitive-Motor Interference Assessment for Improving Neurologic and Physical Disability Outcomes (CAMINANDO) in Survivors of Severe Acute Respiratory Failure

  Hope, A. A.

  3/1/18 → 2/28/22

  Project: Research project

  • Respiratory Insufficiency 100%
  • Acute Lung Injury 60%
  • Mentors 49%
  • Research Personnel 37%
  • National Heart, Lung, and Blood Institute (U.S.) 36%

• Mentoring Junior Investigators to Tackle the Opioid Epidemic

  Starrels, J. L.

  National Institute on Drug Abuse, NATIONAL INSTITUTE ON DRUG ABUSE

  3/1/18 → 2/28/23

  Project: Research project

  • Opioid Epidemic 100%
  • Mentoring 69%
  • Opioid Analgesics 55%
  • Research Personnel 47%
  • HIV 32%

• Resilience to Alzheimer's disease in humans with exceptional longevity

  Barzilai, N. & Zhang, Z.

  National Institute on Aging

  9/15/17 → 5/31/22

  Project: Research project

  • Longevity 100%
  • Alzheimer Disease 89%
  • Aged, 80 and over 61%
  • Genotype 54%
  • Cognition 29%

• Developing and pilot testing an intervention to increase opioid tapering in primary care

  Perez, H. R.

  National Institute on Drug Abuse, NATIONAL INSTITUTE ON DRUG ABUSE

  9/1/17 → 8/31/22

  Project: Research project

  • Opioid Analgesics 100%
  • Primary Health Care 87%
  • Pain 65%
  • Chronic Pain 29%
  • Retention in Care 23%

• Advance Care Coordination and Enhanced Linkage and Retention Among Transitional Re-Entrants Living with Hepatitis C-The HCV-ACCELERATE Trial

  Akiyama, M. J.

  8/15/17 → 3/31/22

  Project: Research project

  • Hepacivirus 100%
  • Criminal Law 35%
  • Mentors 20%
  • Risk-Taking 16%
  • HIV 11%

• Leveraging the electronic health record to reduce opioid analgesic prescriptions

  Bachhuber, M. A.

  8/15/17 → 7/31/22

  Project: Research project

  • Opioid Analgesics 100%
  • Prescriptions 41%
  • Electronic Health Records 28%
  • Implementation Science 10%
  • Research Personnel 9%

• Minimizing losses from HIV care under universal treatment in Rwanda

  Ross, J.

  NATIONAL INSTITUTE OF MENTAL HEALTH, National Institute of Mental Health

  8/4/17 → 7/31/22

  Project: Research project

  • Rwanda 100%
  • HIV 50%
  • Therapeutics 12%
  • Africa South of the Sahara 10%
  • Health Services 8%

• Buprenorphine treatment at syringe exchanges to reduce opioid misuse and HIV risk

  Fox, A. D.

  National Institute on Drug Abuse, NATIONAL INSTITUTE ON DRUG ABUSE

  8/1/17 → 2/28/23

  Project: Research project

  • Buprenorphine 100%
  • Syringes 74%
  • Opioid Analgesics 64%
  • HIV 45%
  • Needle-Exchange Programs 41%

• Advanced Glycation Endproducts and Cardio-Renal Disease

  Kizer, J.

  7/15/17 → 6/30/22

  Project: Research project

  • Advanced Glycation End Products 100%
  • imidazolone 49%
  • Mentors 34%
  • Research Personnel 28%
  • 3-deoxyglucosone 24%

• Advanced Glycation Endproducts and Cardio-Renal Disease

  Kizer, J.

  National Heart, Lung, and Blood Institute

  7/15/17 → 6/30/22

  Project: Research project

  • Advanced Glycation End Products 100%
  • imidazolone 44%
  • Kidney 35%
  • Mentors 31%
  • Research Personnel 26%

• The impact of hydroxychloroquine use on thrombosis and mortality in lupus-related end stage renal disease

  Broder, A. R.

  National Institute of Arthritis and Musculoskeletal and Skin Diseases

  7/1/17 → 6/30/22

  Project: Research project

  • end stage renal disease 100%
  • mortality 51%
  • drug therapy 8%
  • Schools of medicine 6%
  • action plan 6%

• The impact of hydroxychloroquine use on thrombosis and mortality in lupus-related end stage renal disease

  Broder, A. R.

  7/1/17 → 6/30/22

  Project: Research project

  • end stage renal disease 100%
  • mortality 27%
  • drug therapy 7%
  • Schools of medicine 6%
  • action plan 5%

• Does medical cannabis reduce opioid analgesics in HIV+ and HIV- adults with pain?

  Cunningham, C. O.

  7/1/17 → 6/30/22

  Project: Research project

  • Medical Marijuana 100%
  • Opioid Analgesics 41%
  • Cannabidiol 28%
  • HIV 25%
  • Dronabinol 25%

• Does medical cannabis reduce opioid analgesics in HIV+ and HIV- adults with pain?

  Arnsten, J. H. & Cunningham, C. O.

  National Institute on Drug Abuse, NATIONAL INSTITUTE ON DRUG ABUSE

  7/1/17 → 6/30/22

  Project: Research project

  • Medical Marijuana 100%
  • Opioid Analgesics 57%
  • HIV 43%
  • Pain 33%
  • Cannabidiol 30%

• Achieving smoking cessation milestones in opioid treatment patients: a randomized 2 x 2 factorial trial of directly observed and long-term varenicline

  Nahvi, S.

  National Institute on Drug Abuse, NATIONAL INSTITUTE ON DRUG ABUSE

  4/1/17 → 11/30/22

  Project: Research project

  • Varenicline 100%
  • Smoking Cessation 72%
  • Opioid Analgesics 62%
  • Directly Observed Therapy 37%
  • Tobacco 23%

• New York Regional Center for Diabetes Translation Research

  Gonzalez, J., Walker, E. A. & Wylie-Rosett, J.

  National Institute of Diabetes and Digestive and Kidney Diseases

  9/20/16 → 7/31/22

  Project: Research project

  • chronic illness 100%
  • resources 11%
  • health 11%
  • equity 6%
  • study program 5%

• Discordant transcriptional regulation of gluconeogenic and lipogenic gene expression

  Eliscovich, C., Pessin, J. E. & YANG, F. J.

  National Institute of Diabetes and Digestive and Kidney Diseases

  6/15/16 → 6/30/22

  Project: Research project

  • gene expression regulation 100%
  • DNA-directed RNA polymerase 74%
  • insulin resistance 66%
  • liver 53%
  • phosphotransferases (kinases) 46%

• MINORITY-BASED COMMUNITY ONCOLOGY PROGRAM

  Gartrell, B. A., Halmos, B., Rapkin, B. D., Einstein, M. H. & Sparano, J. A.

  National Cancer Institute

  8/1/14 → 7/31/22

  Project: Research project

  • Neoplasms 100%
  • Hispanic Americans 32%
  • African Americans 31%
  • Delivery of Health Care 29%
  • Poverty 26%

• NCI ET-CTN with Phase i Emphasis at UPCI

  Chu, E. & Rose, S. A.

  3/25/14 → 2/28/23

  Project: Research project

  • Clinical Trials 100%
  • Drug Development 48%
  • Therapeutics 25%
  • Cytidine Triphosphate 23%
  • Drug Interactions 16%

• Mechanism of mRNA Localization and Localized Translation in Neurons

  Eliscovich, C., Singer, R. H., Yoon, Y. J. & Singer, R. H.

  National Institute of Neurological Disorders and Stroke

  9/15/13 → 8/31/22

  Project: Research project

  • Neurons 100%
  • Messenger RNA 96%
  • Actins 74%
  • Proteins 42%
  • Synapses 41%